Geiger Uri 4
4 · NeuroPace Inc · Filed Jun 24, 2025
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Geiger Uri
Director
Transactions
- Award
Common Stock
2023-06-30$4.49/sh+2,337$10,493→ 2,337 total - Award
Common Stock
2024-03-29$13.20/sh+899$11,867→ 5,607 total - Award
Common Stock
2024-06-28$7.56/sh+1,570$11,869→ 7,177 total - Award
Common Stock
2025-06-21$10.41/sh+1,140$11,867→ 12,036 total - Award
Common Stock
2023-09-29$9.73/sh+1,220$11,871→ 3,557 total - Award
Common Stock
2023-12-29$10.31/sh+1,151$11,867→ 4,708 total - Award
Common Stock
2024-09-30$6.97/sh+1,703$11,870→ 8,880 total - Award
Common Stock
2024-12-21$11.53/sh+1,029$11,864→ 9,909 total - Award
Common Stock
2025-03-21$12.02/sh+987$11,864→ 10,896 total
Holdings
- 4,432,948(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.
- [F2]Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Geiger, a member of our board of directors, is a General Partner at Accelmed LLC.